Bilinska, Adrianna
Kumar, Naveen
Gnesin, Silvano
Läppchen, Tilman
Menéndez, Elena
Martin, Marcel
Rösch, Frank
Rominger, Axel
Gourni, Eleni https://orcid.org/0000-0003-2198-382X
Funding for this research was provided by:
HORIZON EUROPE European Research Council (No 101073231)
Article History
Received: 8 July 2025
Accepted: 1 September 2025
First Online: 17 October 2025
Declarations
:
: All animal experiments were approved by local authorities and are in compliance with the institutional guidelines (Animal License Nr: BE98/2021).
: Frank Rösch and Marcel Martin filed patents on FAPI-based radioligands; all other authors declare no competing interests. Axel Rominger is an editor of the EJNMMI. All other authors declare no competing interests.